X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sun Pharma with Cadila Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs CADILA HEALTHCARE - Comparison Results

SUN PHARMA     Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUN PHARMA CADILA HEALTHCARE SUN PHARMA/
CADILA HEALTHCARE
 
P/E (TTM) x 31.9 12.7 250.7% View Chart
P/BV x 2.7 2.7 99.9% View Chart
Dividend Yield % 0.5 1.5 30.9%  

Financials

 SUN PHARMA   CADILA HEALTHCARE
EQUITY SHARE DATA
    SUN PHARMA
Mar-18
CADILA HEALTHCARE
Mar-18
SUN PHARMA/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs701558 125.5%   
Low Rs433362 119.8%   
Sales per share (Unadj.) Rs110.4116.3 94.9%  
Earnings per share (Unadj.) Rs11.017.9 61.4%  
Cash flow per share (Unadj.) Rs17.223.1 74.5%  
Dividends per share (Unadj.) Rs2.003.50 57.1%  
Dividend yield (eoy) %0.40.8 46.3%  
Book value per share (Unadj.) Rs158.885.4 185.9%  
Shares outstanding (eoy) m2,399.261,023.74 234.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x5.14.0 129.9%   
Avg P/E ratio x51.625.7 200.7%  
P/CF ratio (eoy) x32.919.9 165.5%  
Price / Book Value ratio x3.65.4 66.3%  
Dividend payout %18.219.6 93.0%   
Avg Mkt Cap Rs m1,360,021470,664 289.0%   
No. of employees `00017.811.8 150.5%   
Total wages/salary Rs m53,67118,545 289.4%   
Avg. sales/employee Rs Th14,890.910,072.7 147.8%   
Avg. wages/employee Rs Th3,017.11,569.1 192.3%   
Avg. net profit/employee Rs Th1,480.61,547.7 95.7%   
INCOME DATA
Net Sales Rs m264,895119,049 222.5%  
Other income Rs m8,3881,132 741.0%   
Total revenues Rs m273,282120,181 227.4%   
Gross profit Rs m56,08128,475 196.9%  
Depreciation Rs m14,9985,388 278.4%   
Interest Rs m5,176911 568.1%   
Profit before tax Rs m44,29523,308 190.0%   
Minority Interest Rs m0628 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-9,5050-   
Tax Rs m8,4525,644 149.8%   
Profit after tax Rs m26,33818,292 144.0%  
Gross profit margin %21.223.9 88.5%  
Effective tax rate %19.124.2 78.8%   
Net profit margin %9.915.4 64.7%  
BALANCE SHEET DATA
Current assets Rs m316,35982,005 385.8%   
Current liabilities Rs m198,64360,720 327.1%   
Net working cap to sales %44.417.9 248.5%  
Current ratio x1.61.4 117.9%  
Inventory Days Days9573 129.6%  
Debtors Days Days10898 109.5%  
Net fixed assets Rs m213,17883,703 254.7%   
Share capital Rs m2,3991,024 234.3%   
"Free" reserves Rs m378,60686,421 438.1%   
Net worth Rs m381,00687,445 435.7%   
Long term debt Rs m17,72125,551 69.4%   
Total assets Rs m643,028180,653 355.9%  
Interest coverage x9.626.6 36.0%   
Debt to equity ratio x00.3 15.9%  
Sales to assets ratio x0.40.7 62.5%   
Return on assets %4.910.6 46.1%  
Return on equity %6.920.9 33.0%  
Return on capital %10.022.0 45.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m40,81642,683 95.6%   
Fx outflow Rs m30,14311,242 268.1%   
Net fx Rs m10,67331,441 33.9%   
CASH FLOW
From Operations Rs m39,0729,193 425.0%  
From Investments Rs m-33,708-9,737 346.2%  
From Financial Activity Rs m-15,393515 -2,988.9%  
Net Cashflow Rs m-7,359-29 25,376.2%  

Share Holding

Indian Promoters % 63.7 74.8 85.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 5.1 8.3 61.8%  
FIIs % 23.0 5.9 389.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 8.3 11.0 75.5%  
Shareholders   133,026 44,069 301.9%  
Pledged promoter(s) holding % 0.5 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUN PHARMA With:   NATCO PHARMA  PANACEA BIOTECH  WOCKHARDT  ABBOTT INDIA  PLETHICO PHARMA  

Compare SUN PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 560 Points Lower; Auto and Banking Stocks Witness Huge Selling(Closing)

India share markets continued to witness selling pressure during closing hours and ended their day deep in the red.

Related Views on News

SUN PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 53.4% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, SUN PHARMA has posted a net profit of Rs 7 bn (down 53.4% YoY). Sales on the other hand came in at Rs 72 bn (up 2.7% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

SUN PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 265.5% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUN PHARMA has posted a net profit of Rs 15 bn (up 265.5% YoY). Sales on the other hand came in at Rs 77 bn (up 16.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Here's What to Do with Falling Small Cap Stocks(Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

Budget an Icing on the Cake for This Smart Money Backed Affordable Housing Stock(The 5 Minute Wrapup)

Jul 10, 2019

Affordable housing is one of the most straightforward growth stories in India. This will help the real estate sector to come out of the slump.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Jul 19, 2019 03:35 PM

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA 8-QTR ANALYSIS

COMPARE SUN PHARMA WITH

MARKET STATS